Prolonged subcutaneous administration of oxytocin accelerates angiotensin II-induced hypertension and renal damage in male rats

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Phie, James ^a   Haleagrahara, Nagaraja ^a   Newton, Patricia ^a   Constantinoiu, Constantin ^a   Sarnyai, Zoltan ^a   Chilton, Lisa ^a   Kinobe, Robert ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CALCINEURIN; OXYTOCIN; RENIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVATION; HEART LEFT VENTRICLE HYPERTROPHY; HEMODYNAMIC PARAMETERS; HYPERTENSION; KIDNEY INJURY; LONG TERM EXPOSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PLASMA RENIN ACTIVITY; RAT; SPRAGUE DAWLEY RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; CARDIOMEGALY; CHEMICALLY INDUCED; DRUG EFFECTS; KIDNEY; METABOLISM; PATHOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANGIOTENSIN II; ANIMALS; ATRIAL NATRIURETIC FACTOR; CALCINEURIN; CARDIOMEGALY; HYPERTENSION; INJECTIONS, SUBCUTANEOUS; KIDNEY; MALE; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RENIN;

EID: 84947740430     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0138048     Document Type: Article

References (49)

1. Bakermans-Kranenburg M, Van Ijzendoorn M. Sniffing around oxytocin: Review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry. 2013; 3 (5): E258.
2. Cochran D, Fallon D, Hill M, Frazier JA. The role of oxytocin in psychiatric disorders: A review of biological and therapeutic research findings. Harv Rev Psychiatry. 2013; 21(5): 219. doi: 10.1097/HRP. 0b013e3182a75b7d PMID: 24651556
3. Anagnostou E, Soorya L, Brian J, Dupuis A, Mankad D, Smile S, et al. Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth. Brain Res. 2014; 1580: 188-98. doi: 10.1016/j.brainres.2014.01.049 PMID: 24508578
4. Jankowski M, Hajjar F, Al Kawas S, Mukaddam-Daher S, Hoffman G, McCann SM, et al. Rat heart: A site of oxytocin production and action. Proc Natl Acad Sci U S A. 1998; 95(24): 14558-63. PMID: 9826739
5. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human Vascular Endothelial Cells Express Oxytocin Receptors. Endocrinology. 1999; 140(3): 1301-9. PMID: 10067857
6. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci U S A. 1997; 94(21): 11704-9. PMID: 9326674
7. Haanwinckel M, Elias L, Favaretto A, Gutkowska J, McCann S, Antunes-Rodrigues J. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci U S A. 1995; 92(17): 7902-6. PMID: 7644511
8. Mukaddam-Daher S, Yin Y-L, Roy J, Gutkowska J, Cardinal R. Negative inotropic and chronotropic effects of oxytocin. Hypertension. 2001; 38(2): 292-6. PMID: 11509492
9. Rigatto K, Puryear R, Bernatova I, Morris M. Salt Appetite and the Renin-Angiotensin System Effect of Oxytocin Deficiency. Hypertension. 2003; 42(4): 793-7. PMID: 12953013
10. Alizadeh AM, Faghihi M, Sadeghipour HR, Mohammadghasemi F, Imani A, Houshmand F, et al. Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATPdependent potassium channel. Peptides. 2010; 31(7): 1341-5. doi: 10.1016/j.peptides.2010.04.012 PMID: 20417240
11. Jankowski M, Bissonauth V, Gao L, Gangal M, Wang D, Danalache B, et al. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol. 2010; 105(2): 205-18. doi: 10.1007/s00395- 009-0076-5 PMID: 20012748
12. Faghihi M, Alizadeh AM, Khori V, Latifpour M, Khodayari S. The role of nitric oxide, reactive oxygen species, and protein kinase C in oxytocin-induced cardioprotection in ischemic rat heart. Peptides. 2012; 37(2): 314-9. doi: 10.1016/j.peptides.2012.08.001 PMID: 22902709
13. Garg V, Hu K. Protein kinase C isoform-dependent modulation of ATP-sensitive K+ channels in mitochondrial inner membrane. Am J Physiol Heart Circ Physiol. 2007; 293(1): H322-H32. PMID: 17351068
14. Costa AD, Quinlan CL, Andrukhiv A, West IC, Jaburek M, Garlid KD. The direct physiological effects of mitoKATP opening on heart mitochondria. Am J Physiol Heart Circ Physiol. 2006; 290(1): H406-H15. PMID: 16143645
15. Costa AD, Jakob R, Costa CL, Andrukhiv K, West IC, Garlid KD. The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem. 2006; 281(30): 20801-8. PMID: 16720572
16. Frantz S, Hu K, Adamek A, Wolf J, Sallam A, Maier SK, et al. Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol. 2008; 103(5): 485-92. doi: 10.1007/s00395-008-0739-7 PMID: 18651091
17. Chen H, Li D, Saldeen T, Mehta JL. TGF-ß1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1. Am J Physiol Heart Circ Physiol. 2003; 284(5): H1612-H7. PMID: 12679326
18. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, et al. Transforming growth factor-ß function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation. 2002; 106(1): 130-5. PMID: 12093782
19. Monga M, Campbell DF, Sanborn BM. Oxytocin-stimulated capacitative calcium entry in human myometrial cells. Am J Obstet Gynecol. 1999; 181(2): 424-9. PMID: 10454695
20. Pont JN, McArdle CA, López Bernal A. Oxytocin-stimulated NFAT transcriptional activation in human myometrial cells. Mol Endocrinol. 2012; 26(10): 1743-56. PMID: 22902539
21. Molkentin JD. Calcineurin-NFAT signaling regulates the cardiac hypertrophic response in coordination with the MAPKs. Cardiovasc Res. 2004; 63(3): 467-75. PMID: 15276472
22. Wilkins BJ, Dai Y-S, Bueno OF, Parsons SA, Xu J, Plank DM, et al. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2004; 94(1): 110-8. PMID: 14656927
23. Inoue T, Kimura T, Azuma C, Inazawa J, Takemura M, Kikuchi T, et al. Structural organization of the human oxytocin receptor gene. J Biol Chem. 1994; 269(51): 32451-6. PMID: 7798245
24. Menaouar A, Florian M, Wang D, Danalache B, Jankowski M, Gutkowska J. Anti-hypertrophic effects of oxytocin in rat ventricular myocytes. Int J Cardiol. 2014;(0). doi: Http: //dx.doi.org/10.1016/j.ijcard.2014. 04.174
25. Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol Endocrinol Metab. 1998; 274(5): E867-E76.
26. Griffin SA, Brown W, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension. 1991; 17(5): 626-35. PMID: 2022407
27. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K. Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens. 2008; 21(12): 1288-91. doi: 10.1038/ajh. 2008.301 PMID: 18846043
28. Papadopulos F, Spinelli M, Valente S, Foroni L, Orrico C, Alviano F, et al. Common tasks in microscopic and ultrastructural image analysis using ImageJ. Ultrastruct Pathol. 2007; 31(6): 401-7. PMID: 18098058
29. Dam VP, Scott JL, Ross A, Kinobe RT. Inhibition of cystathionine gamma-lyase and the biosynthesis of endogenous hydrogen sulphide ameliorates gentamicin-induced nephrotoxicity. Eur J Pharmacol. 2012; 685(1): 165-73.
30. Moorhead KT, Hill JV, Chase JG, Hann CE, Scotter JM, Storer MK, et al. Modelling acute renal failure using blood and breath biomarkers in rats. Comput Methods Programs Biomed. 2011; 101(2): 173-82. doi: 10.1016/j.cmpb.2010.07.010 PMID: 20728235
31. Rössger K, Charpin-El Hamri G, Fussenegger M. Reward-based hypertension control by a synthetic brain-dopamine interface. Proc Natl Acad Sci U S A. 2013; 110(45): 18150-5. doi: 10.1073/pnas. 1312414110 PMID: 24127594
32. Martin B, Pallen C, Wang J, Graves DJ. Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem. 1985; 260 (28): 14932-7. PMID: 2415511
33. Pinheiro J, Bates D. Mixed-effects models in S and S-PLUS: Springer Science & Business Media; 2006.
34. Brink M, Wellen J, Delafontaine P. Angiotensin II causes weight loss and decreases circulating insulinlike growth factor I in rats through a pressor-independent mechanism. J Clin Invest. 1996; 97(11): 2509. PMID: 8647943
35. Huang W, Sjöquist M, Skott O, Stricker EM, Sved AF. Oxytocin antagonist disrupts hypotensionevoked renin secretion and other responses in conscious rats. Am J Physiol Regul Integr Comp Physiol. 2001; 280(3): R760-R5. PMID: 11171655
36. Wsol A, Szczepanska-Sadowska E, Kowalewski S, Puchalska L, Cudnoch-Jedrzejewska A. Oxytocin differently regulates pressor responses to stress in WKY and SHR rats. The role of central oxytocin and V1a receptors. Stress. 2014; 17(1): 117-25. doi: 10.3109/10253890.2013.872620 PMID: 24308490
37. Petersson M, Alster P, Lundeberg T, UvnÄS-Moberg K. Oxytocin Causes a Long-Term Decrease of Blood Pressure in Female and Male Rats. Physiol Behav. 1997; 60(5): 1311-5.
38. Morris M, Callahan MF, Li P, Lucion AB. Central Oxytocin Mediates Stress-Induced Tachycardia. J Neuroendocrinol. 1995; 7(6): 455-9. PMID: 7550292
39. Morin V, del Castillo JR, Authier S, Ybarra N, Otis C, Gauvin D, et al. Evidence for non-linear pharmacokinetics of oxytocin in anesthetizetized rat. J Pharm Pharmaceut Sci. 2008; 11: 12-24.
40. Loichot C, Krieger J-P, De Jong W, Nisato D, Imbs J-L, Barthelmebs M. High concentrations of oxytocin cause vasoconstriction by activating vasopressin V1A receptors in the isolated perfused rat kidney. Naunyn-Schmiedeberg's Arch Pharmacol. 2001; 363(4): 369-75.
41. Cudnoch-Jedrzejewska A, Dobruch J, Puchalska L, Szczepanska-Sadowska E. Interaction of AT1 receptors and V1a receptors-mediated effects in the central cardiovascular control during the postinfarct state. Regul Pept. 2007; 142(3): 86-94. PMID: 17350115
42. Schiltz JC, Hoffman GE, Stricker EM, Sved AF. Decreases in arterial pressure activate oxytocin neurons in conscious rats. Am J Physiol Regul Integr Comp Physiol. 1997; 273(4): R1474-R83.
43. Chen L, Kim SM, Eisner C, Oppermann M, Huang Y, Mizel D, et al. Stimulation of renin secretion by angiotensin II blockade is Gsa-dependent. J Am Soc Nephrol. 2010; 21(6): 986-92. doi: 10.1681/ASN. 2009030307 PMID: 20395378
44. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006; 103(47): 17985-90. PMID: 17090678
45. Ibebuogu UN, Gladysheva IP, Houng AK, Reed GL. Decompensated Heart Failure Is Associated With Reduced Corin Levels and Decreased Cleavage of Pro-Atrial Natriuretic Peptide. Circ Heart Fail. 2011; 4(2): 114-20. doi: 10.1161/CIRCHEARTFAILURE.109.895581 PMID: 21216831
46. O'Brien R. N-terminal pro-atrial natriuretic peptide (N-ANP) and N-terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction. Clin Sci. 2004; 107: 309-16. PMID: 15182235
47. Plante E, Menaouar A, Danalache BA, Yip D, Broderick TL, Chiasson J-L, et al. Oxytocin Treatment Prevents the Cardiomyopathy Observed in Obese Diabetic Male db/db Mice. Endocrinology. 2015; 156 (4): 1416-28. doi: 10.1210/en.2014-1718 PMID: 25562615
48. Morton GJ, Thatcher BS, Reidelberger RD, Ogimoto K, Wolden-Hanson T, Baskin DG, et al. Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab. 2012; 302(1): E134-E44. doi: 10.1152/ajpendo.00296.2011 PMID: 22008455
49. Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrology Dialysis Transplantation. 2003; 18(10): 1999-2004.